PROGNOSIS OF BRONCHIAL ASTHMA RISK Russian patent published in 2006 - IPC A61B10/00 

FIELD: medicine, in particular pulmonology.

SUBSTANCE: patient is tested for pollen, dust and food allergy, and for antibiotic, analgesic and aspirin intolerance. Relations suffering from asthma are checked. Also checked are patient amenability to respiratory infections more than twice for one year and nasal asthma; presence of atopic dermatitis, eczema, urticaria fever and other allergic syndromes, presence of liver or gastrointestinal tract diseases, and presence of professional harmfulness. Bronchial asthma (BA) risk is predicted in accordance with formula R=(S/(S+1))*100 %, wherein S = 0,0526·9^x1·6^x2·4^x3·7^x4·3^x5·2^x6·20^x7·6^x8·2^x9·15^x10·3^x11. 1; X1 is presence of relations suffering from BA: presence -1; absence - 0; X2 is presence of three or more relations suffering from BA: presence -1; absence - 0; X3 is amenability to respiratory infections more than twice for one year: presence -1; absence - 0; X4 is amenability to nasal asthma: presence -1; absence - 0; X5 is presence of atopic dermatitis: presence -1; absence - 0; X6 is presence of liver or gastrointestinal tract diseases: presence -1; absence - 0; X7 is test for pollen and dust allergy: positive - 1; negative - 0; X8 - test for food allergy: positive - 1; negative - 0; X9 is antibiotic intolerance: presence -1; absence - 0; X10 is analgesic or aspirin intolerance: presence -1; absence - 0; X11 is presence of professional harmfulness: presence -1; absence - 0. When R>70 % high bronchial asthma risk, R = 50-70 % middle risk, and R<50 % low risk are predicted.

EFFECT: bronchial asthma risk prognosis with increased accuracy.

3 ex, 4 tbl